Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Abamectin + fenpyroximate is a combination pesticide product used primarily in agriculture and pest control. Abamectin is a macrocyclic lactone derived from the fermentation of Streptomyces avermitilis, acting as a broad-spectrum antiparasitic and insecticide/acaricide. Its mechanism involves binding to glutamate-gated chloride channels in nerve and muscle cells of invertebrates, leading to paralysis and death by increasing chloride ion influx. Fenpyroximate is an acaricide belonging to the pyrazole class; it acts as a mitochondrial electron transport inhibitor (METI), specifically inhibiting complex I (NADH-coenzyme Q reductase) in the mitochondrial respiratory chain, resulting in energy depletion and death of target pests. The combination targets mites, leafminers, aphids, thrips, whiteflies, nematodes, and other agricultural pests resistant to single-agent treatments. This mixture can be formulated for foliar application or incorporated into substrates such as mosquito nets or wall linings for vector control[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on abamectin + fenpyroximate.